At the news
? NEUTRALIMPACT 2/10 144 filed Nov 2, 2026 at 16:11 ET
Joseph LaRosa, an officer of Regeneron Pharmaceuticals, filed a Form 144 notice of intent to sell 4,466 shares of common stock with an approximate market value of $4.3 million, based on a filing date of November 2, 2026. The shares were acquired via stock option exercise on January 3, 2024, and the sale is planned for execution on or after November 2, 2026.
- Joseph LaRosa (Officer) filed Form 144 to sell 4,466 shares of Regeneron common stock.
- Estimated market value of proposed sale: $4,311,875.12.
- Shares were acquired via stock option exercise on January 3, 2024.
- Proposed sale date: November 2, 2026.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access